Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313334635> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W4313334635 endingPage "70" @default.
- W4313334635 startingPage "64" @default.
- W4313334635 abstract "Primary aim was to assess the safety of SGLT2-i in patients with Type 2 Diabetes Mellitus (T2D) in a real-life scenario during Ramadan by finding the frequency and severity of hypoglycemic/hyperglycemic events, dehydration, and Diabetic ketoacidosis (DKA). Secondary aim was to assess changes in glycated hemoglobin (HbA1c), weight and creatinine levels.This prospective, observational, controlled cohort study was conducted at Aga Khan University Hospital, Karachi, Pakistan from March 15 to June 30, 2021. Participants were over 21 years of age, on stable doses of SGLT2-I, which was started at least 2 months before Ramadan. Endpoint assessments were done 1 month before and within 6 weeks after Ramadan.Of 102 participants enrolled, 82 completed the study. Most (52%) were males, with mean age 52.2 ± 9.5 years and average duration of T2D 11.2 ± 6.5 years. 63% were on Empagliflozin (mean dose; 14.8 ± 7.2 mg/day) whereas 37% were on Dapagliflozin (mean dose; 8.2 ± 2.7 mg/day). Six (7.3%) documented symptoms of hypoglycemia. However, no episode of severe hypoglycemia, hyperglycemia, dehydration, DKA, hospitalization or discontinuation of SGLT2i was reported. HbA1c changes were (7.7 ± 1.2% from 7.9 ± 2.3%, p 0.34), weight (78.4 ± 12.9 kgs from 78.9 ± 13.3, p 0.23) and eGFR (87.8 ± 27.9 from 94.3 ± 37.6, p < 0.001). The reasons of study participants drop outs were: six did not keep any fasts; four discontinued study participation for personal reasons; three were out of city and missed post Ramadan follow-up, two protocol violation and five could not be contacted for post-Ramadan follow up during the third wave of COVID-19.Results showed the safety of SGLT2i agents during Ramadan in the Pakistani population recommending it as a treatment option in adults with T2D, without any additional adverse events." @default.
- W4313334635 created "2023-01-06" @default.
- W4313334635 creator A5000199010 @default.
- W4313334635 creator A5011108358 @default.
- W4313334635 creator A5040003498 @default.
- W4313334635 creator A5065782520 @default.
- W4313334635 date "2022-12-29" @default.
- W4313334635 modified "2023-10-18" @default.
- W4313334635 title "Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2i) during the month of Ramadan in patients with type 2 diabetes mellitus in Pakistani population—an observational study from a tertiary care center in Karachi" @default.
- W4313334635 cites W1976237233 @default.
- W4313334635 cites W2023738827 @default.
- W4313334635 cites W2081810385 @default.
- W4313334635 cites W2095426009 @default.
- W4313334635 cites W2182461571 @default.
- W4313334635 cites W2342731449 @default.
- W4313334635 cites W2546784514 @default.
- W4313334635 cites W2796876561 @default.
- W4313334635 cites W2898388822 @default.
- W4313334635 cites W2911574701 @default.
- W4313334635 cites W2918155206 @default.
- W4313334635 cites W2974260792 @default.
- W4313334635 cites W3021583569 @default.
- W4313334635 cites W3046159964 @default.
- W4313334635 cites W3088173406 @default.
- W4313334635 cites W3091067403 @default.
- W4313334635 cites W3093992036 @default.
- W4313334635 cites W3158421196 @default.
- W4313334635 cites W3171984890 @default.
- W4313334635 cites W3177037950 @default.
- W4313334635 cites W4200557842 @default.
- W4313334635 cites W4205993681 @default.
- W4313334635 cites W4211020598 @default.
- W4313334635 cites W4226356934 @default.
- W4313334635 cites W3125731495 @default.
- W4313334635 doi "https://doi.org/10.1007/s12020-022-03290-7" @default.
- W4313334635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36580199" @default.
- W4313334635 hasPublicationYear "2022" @default.
- W4313334635 type Work @default.
- W4313334635 citedByCount "1" @default.
- W4313334635 countsByYear W43133346352023 @default.
- W4313334635 crossrefType "journal-article" @default.
- W4313334635 hasAuthorship W4313334635A5000199010 @default.
- W4313334635 hasAuthorship W4313334635A5011108358 @default.
- W4313334635 hasAuthorship W4313334635A5040003498 @default.
- W4313334635 hasAuthorship W4313334635A5065782520 @default.
- W4313334635 hasBestOaLocation W43133346351 @default.
- W4313334635 hasConcept C126322002 @default.
- W4313334635 hasConcept C134018914 @default.
- W4313334635 hasConcept C187212893 @default.
- W4313334635 hasConcept C23131810 @default.
- W4313334635 hasConcept C2777180221 @default.
- W4313334635 hasConcept C2777422806 @default.
- W4313334635 hasConcept C2777538456 @default.
- W4313334635 hasConcept C2778715236 @default.
- W4313334635 hasConcept C2780668416 @default.
- W4313334635 hasConcept C2781283889 @default.
- W4313334635 hasConcept C2908647359 @default.
- W4313334635 hasConcept C2910068830 @default.
- W4313334635 hasConcept C555293320 @default.
- W4313334635 hasConcept C71924100 @default.
- W4313334635 hasConcept C99454951 @default.
- W4313334635 hasConceptScore W4313334635C126322002 @default.
- W4313334635 hasConceptScore W4313334635C134018914 @default.
- W4313334635 hasConceptScore W4313334635C187212893 @default.
- W4313334635 hasConceptScore W4313334635C23131810 @default.
- W4313334635 hasConceptScore W4313334635C2777180221 @default.
- W4313334635 hasConceptScore W4313334635C2777422806 @default.
- W4313334635 hasConceptScore W4313334635C2777538456 @default.
- W4313334635 hasConceptScore W4313334635C2778715236 @default.
- W4313334635 hasConceptScore W4313334635C2780668416 @default.
- W4313334635 hasConceptScore W4313334635C2781283889 @default.
- W4313334635 hasConceptScore W4313334635C2908647359 @default.
- W4313334635 hasConceptScore W4313334635C2910068830 @default.
- W4313334635 hasConceptScore W4313334635C555293320 @default.
- W4313334635 hasConceptScore W4313334635C71924100 @default.
- W4313334635 hasConceptScore W4313334635C99454951 @default.
- W4313334635 hasIssue "1" @default.
- W4313334635 hasLocation W43133346351 @default.
- W4313334635 hasLocation W43133346352 @default.
- W4313334635 hasLocation W43133346353 @default.
- W4313334635 hasLocation W43133346354 @default.
- W4313334635 hasOpenAccess W4313334635 @default.
- W4313334635 hasPrimaryLocation W43133346351 @default.
- W4313334635 hasRelatedWork W2011278875 @default.
- W4313334635 hasRelatedWork W2113297547 @default.
- W4313334635 hasRelatedWork W2250325680 @default.
- W4313334635 hasRelatedWork W2297099908 @default.
- W4313334635 hasRelatedWork W2407090453 @default.
- W4313334635 hasRelatedWork W2790772209 @default.
- W4313334635 hasRelatedWork W2954412169 @default.
- W4313334635 hasRelatedWork W2969337159 @default.
- W4313334635 hasRelatedWork W3126557659 @default.
- W4313334635 hasRelatedWork W3152935002 @default.
- W4313334635 hasVolume "80" @default.
- W4313334635 isParatext "false" @default.
- W4313334635 isRetracted "false" @default.
- W4313334635 workType "article" @default.